Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 EFSA Panel Approves Hydroxytyrosol for Heart-Health Claims - Nutraceuticals World

What are you searching for?

Sign in
Regulations

EFSA Panel Approves Hydroxytyrosol for Heart-Health Claims

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

The European Foods Safety Authority (EFSA) has issued a scientific opinion on health claims in relation to dietary consumption of hydroxytyrosol and related polyphenol compounds from olive fruit and oil and protection of blood lipids from oxidative damage, which is known to affect cardiovascular health adversely. On the basis of the data presented, EFSA concluded that a cause-and-effect relationship has been established between the consumption of hydroxytyrosol and related compounds from olives and olive oil and protection of blood lipids from oxidative damage. EFSA determined that a minimum 5 mg of Hydroxytyrosol and its derivatives in olive oil should be consumed daily to use a cardiovascular health claim. Hydroxytyrosol is the active ingredient in Hytolive, a proprietary extract of olive fruit manufactured by Genosa ID, S.A., Malaga, Spain and distributed by PL Thomas, Morristown, NJ. Hytolive has a high concentration of natural hydroxytyrosol, the active and most abundant ortho-diphenol found in the olive fruit.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics